Global Blood Therapeutics, Inc. S-1, filed Jul 8, 2015: EX-23.1
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Global Blood Therapeutics, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
July 8, 2015